The molecular limitations of biomarker research in bladder cancer

Volume: 37, Issue: 5, Pages: 837 - 848
Published: Aug 31, 2018
Abstract
Urothelial carcinoma of the bladder (UCB) is a common malignancy with limited systemic treatment options in advanced stages. Despite recent advances in immunotherapy, the majority of patients do not respond to these treatments. There is an unmet need for developing robust biomarkers to inform treatment decisions and identify patients who are likely to respond. A MEDLINE/PubMed literature search was performed, focusing on tissue-based and...
Paper Details
Title
The molecular limitations of biomarker research in bladder cancer
Published Date
Aug 31, 2018
Volume
37
Issue
5
Pages
837 - 848
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.